United States · FDA National Drug Code directory
Nintedanib Capsules, 100 mg and 150 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-787_e6cab487-5092-4b7b-a3c2-da94f6dc66c2
- Product NDC
- 76282-787
- Form
- CAPSULE
- Composition / generic term
- Nintedanib
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260507
- Source listing expiry
- 20271231
Source-listed ingredients
- NINTEDANIB ESYLATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (76282-787-60) · 76282-787-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →